Counterfeiting has a long history. For most commodities it is simply the theft of brand owners' intellectual property, a trademark violation. But fake medicines can also kill. Political wrangling over language, and confusion over how to deal with the public health and private property aspects of counterfeiting, is hampering international action.
Counterfeit, falsified and substandard medicines pose a considerable threat to health. Although detailed knowledge of their prevalence and impact on human well-being is limited, they can fail to cure, promote antimicrobial resistance, and ultimately kill. The threat from these medicines is probably growing, particularly in poorer countries with weak regulation and poorly monitored distribution networks.
Counterfeiting can be very profitable, and those who do it are becoming increasingly sophisticated, which makes patients in developing countries, who usually have to buy medicines from their own resources, particularly vulnerable.
Deception of one kind or another has been practised for millennia. Counterfeiting of money is its oldest form and has been around almost since coins were invented. The United States Secret Service was established in 1865 for the express purpose of suppressing fake currency and this remains one of its major functions. For a long time, money counterfeiting was predominant. However, in the modern age, it is most often associated with the imitation of major brand name consumer goods.
Traditionally counterfeiting is defined by the Oxford English Dictionary as: 'made in exact imitation of something valuable with the intention to deceive or defraud others.' In intellectual property law it refers more specifically to certain kinds of trademark violation. However, it is often used much more loosely to refer to any product which seeks to deceive the consumer into believing it is something it is not.
For many goods, such as clothing or accessories, the effect of counterfeiting is principally financial and economic. Employment and income may be diverted from brand name manufacturers to counterfeiters, and consumers may benefit from lower prices, or lose from poor quality imitations. Essentially, income is redistributed between brand owners, counterfeiters and consumers. The extent to which economic losses fall on the brand owner are disputed, because counterfeiting may also expand the market for a brand.
In the case of food, medicines, cosmetics and some other goods, counterfeiting can also pose a serious threat to human health because products are likely to be either substandard or contain positively dangerous components or ingredients. This kind of counterfeiting is thus qualitatively different from, for example, a fake Rolex watch.
Numerous industry groups combat counterfeiting, principally by lobbying for strengthened intellectual property rights globally and for stronger enforcement. For instance the
Such groups principally represent mainstream consumer and other goods particularly prone to counterfeiting, with the motive of protecting their business interests. For example, the current IACC executive committee includes representatives from Rolex,
Doubts About Drugs
Pharmaceutical products are a rather special case for several reasons. Typically it is more difficult to decide whether a product is counterfeit or not, not least because the consumer or prescriber cannot know the contents of the medicine. Before they can be legally marketed, medical products are, at least in principle, subject to much stronger regulation concerning their safety and quality than other items. Bodies such as the
The general war on counterfeits is principally about protecting markets and private intellectual property rights, but in the case of pharmaceuticals this self-interested motive is overlaid by a concern to protect public health. The combination of self-interested and altruistic motives can be confusing to observers, and suspicious to some.
Pharmaceutical companies can be very guarded about the issue. Publicising particular cases can lead to diminished sales because patients or doctors lose confidence in the quality of the brand. In addition, it is legal to market generic medicines that are essentially identical to the brand name product where there is no patent or the patent has expired. This can lead to confusion between legally marketed identical copies - which must be differently branded - and illegal counterfeit products, which imitate the brand.
Because of these sensitivities the main industry-supported anti-counterfeiting pharmaceutical body, the
For example, last year it recorded 978 counterfeit seizures out of 2,003 incidents, including diversions and theft, of which 48 percent were on a commercial scale. Beyond that there are some very general statistics on geographical distribution of incidents and arrests, and the broad therapeutic areas affected by incidents: cardiovascular and alimentary.
Similarly, the national and international bodies involved in combating counterfeit medicines - police, customs, regulatory authorities - are reluctant to detail their activities, not least because of the information they might provide to counterfeiters about their methods.
Thus the circumstances of medicines counterfeiting means that reliable data on its true extent, and in particular the harm it does to human health, is particularly scarce. Estimates of deaths from counterfeits, such as the 700,000 deaths annually from fake malaria and tuberculosis drugs alone, claimed by one study last year are to be treated with extreme scepticism. Nevertheless, counterfeits are certainly everywhere and a serious threat to public health.
Conflict of Interests
However, the issue of counterfeit medicines has recently become extremely controversial. The definition that the
Thus, counterfeits become inextricably confused with medicines that are falsified in some other way - for example by concealing their true identity and source - and medicines that are simply substandard: not containing ingredients to the specifications required by regulatory authorities.
Some countries strongly contend that counterfeiting is principally an issue of intellectual property, and expressed their concern that WHO, by using the term counterfeit and providing the secretariat for IMPACT, was becoming involved in the enforcement of privately owned intellectual property rights without the endorsement of all its member states. Rather they argued that WHO's role should be to combat substandard drugs - of whatever origin - as part of its mandate to protect public health.
In addition, concerns have been raised that anti-counterfeiting measures might lead to threats to the legitimate trade in generic drugs. These concerns were made worse by the detention in the
There are also suspicions over the possible impact of the Anti-Counterfeiting Trade Agreement (ACTA) being negotiated between developed countries and some emerging economies to establish higher international standards for intellectual property rights enforcement, as well as the bilateral free trade agreements between developed and developing countries, which frequently seek to include a similar strengthening of intellectual property rules and enforcement beyond the minimum standards laid down in TRIPS.
Undoubtedly, no one supports the work of the counterfeiters, with the harm they can do to sick people. The controversies are a reflection, in part, of perceived conflicts of economic interest between countries with brand name and generic pharmaceutical industries in the means used to tackle counterfeiting, as well as substandard medicines in general. Overcoming these perceptions of conflicting interest, including ensuring that definitions and rules and procedures do not discriminate between generic and brand name products, will be the key to more effective anticounterfeiting measures.
Charles Clift is in the Centre on Global Health Security at Chatham House, which is investigating this issue.
Available at Amazon.com:
- A World Full of Fault Lines
- Facebook, Twitter and the Search for Peace in the Middle East
- China's Leadership: Fractures Finally Showing
- China: Uncertain Leap Forward
- Britain and China: Being Friendly
- Belarus: Land Between
- Sudan's Referendum: Prickly Interdependence
- Saudi Arabian Foreign Policy: Limits of Being Helpful
- Iraq Refugees: Seeking Safety
- Troublesome Partner in Afghanistan
- NATO Presses on With Futile Effort in Afghanistan
- Counterfeit Medicines: Health and Harm
- Food Supply: Lunchtime Blues
- Cybersecurity and Society: bigsociety.com
- America's Credibility Deficit
- Global Warming Conference Faces Meltdown
- WikiLeaks Disclosures Not Earth Shattering
- WikiLeaks May End Up Helping America
- WikiLeaks and The Invisible Government
- Wikileaks: More Than Just an Embarrassment
- Wikileaks: Undiplomatic Diplomacy
- A WikiLeaks Wake-up Call
- Will WikiLeaks Hobble U.S. Diplomacy?
- How WikiLeaks Can Make Us Less Free
- Wikileaks: Small Revelations That May Cause a Big Idea to Take Hold
- G20 Summit: Hitting Singles in Seoul
- The Consequences of Fiscal Irresponsibility
- GDP Now Matters More Than Force: Policy for the Age of Economic Power
- What Population Growth and Decline Means for the Global Economy
- Leading Through Civilian Power: Redefining Diplomacy and Development
- The Future of American Power: Dominance and Decline in Perspective
- Who Do You Call If You Want to Divide Europe?
- The Game Changer: Coping With China's Foreign Policy Revolution
- Why the Retirement Age Is Increasing
- Religion's Growing Influence in International Politics
- The Difficulty of Integrating Rising Powers
- Ban-ki Moon Has United Nations 'Drifting Into Irrelevance'
- Bachelet Faces Uphill Battle at U.N. Women
- Murderous Tactics Fueling Terrorist Propaganda
- Benjamin Netanyahu: A Hawk in the Ointment
- Diminished Capacity
- Moscow's Modernization Dilemma: Is Russia Charting a New Foreign Policy?
- NATO Summit Unlikely to Answer the Most Important Questions
- Franco-German Call for Change in the EU Meets with Much Opposition
- A Tenuous Deal in Iraq
- Conflict or Cooperation? Three Visions Revisited
- A New Global Player: Brazil's Far-Flung Agenda
- Pax Ottomana? The Mixed Success of Turkey's New Foreign Policy
- Rise of the Mezzanine Rulers
- Globalizing the Energy Revolution
- Democracy in Cyberspace
- The Digital Disruption
- Africa: Agriculture's Final Frontier
- A Reading List for the Twenty-first Century
- Latin American Leaders Could Have Learned From South Korea
- Region Ignoring Venezuela Coup Threats
- To Fight Corruption, Start Cutting Red Tape
- New Congress Won't Lead to 'Fortress America'
- The Shifting Balance of Power
- Checking China's Territorial Moves
- Why China Has a Point About Quantitative Easing
- China's Rate Hike: Winners and Losers
- Taiwan's Shadow
- Fools Rush in Where Europe Rushes Out
- Germany to Muhammad: Go Home
- Can NATO Nudge Russia Westward?
- French Demonstrations Tell a Familiar Tale
- Chavez a Pain for Spain
- Nestor Kirchner's Death May Mark End of an Era
- Petraeus Follows Iraq Formula in Afghanistan
- Heavy Handed Intervention Has Stalled Arab-Israeli Peace Process
- George Clooney Urges Obama and Media To Focus On Sudan
- Fighting Hunger in Des Moines
- Rise in Tourism to Miami May Signal Danger Ahead
- Peru May Be Next Latin American Success Story
- Nobel Winner Right About Risks of e-Books
- Nestor Kirchner's Death May Mark End of an Era
- Chavez a Pain for Spain
- Economic Woes Put Brittle Nations on Edge
- A Divided and Insular European Union
- Do not Expect China to Budge on the Yuan
- Why on Earth Does America Want a Stronger Chinese Currency?
- Nuclear Club Has Yet Another Applicant
- Nuclear Armament Still Our Central Issue
- Embattled Islam
- 'Europe Looks East' Hints at the Future
- Choosing Between the Evil of Two Lessers In Afghanistan
- Chavez Lost Ground but Will Fight Back
- Education Too Important to Be Left in Government Hands
- Latin America In Denial About the Quality of Its Schools
- Millennium Development Goals for Women Largely Unmet
- North Korean Succession Plans Are Shrouded in Mystery
- Rogue BFFs North Korea and Iran Make Quite a Pair
- American Role in Israeli-Palestinian Talks Is a Problem
- Iraq Reluctant to Pay Its Fair Share of Security Costs
- Iran's 'Shaky' Ahmadinejad
- United States Could Be Alone as Europe Turns Inward
- Hugo Chávez May Lose Even if He Wins
- Brazil Needs Dose of Constructive Paranoia
- Latin American Commodity Exporters Need to Diversify
- Stoned on Righteousness
- Our Man in Moscow
- Widening Divide in American-Chinese Commercial Interests
- The New Old World Order
- Global Human-Rights Cause Gets a Shot in the Arm
- Obama's Foreign Policy Performance
- New Russia Takes Root in Saint Petersburg and Moscow
- Dismantling Worst-Case Proliferation Scenarios
- A Numbers Game in the Middle East
- Middle East Peace Talks: Here We Go Again
- Obama and Clinton Revive Middle East Peace Talks
- Guess Who's Coming to the Table
- Iraq: Unanswered Policy Questions on U.S. Troops
- Iraq: Implications of a Pointless War
- Iraq: Book Review
- Iraq: No Drums and No Bugles: None Dare Call It Victory
- Pakistan's Leadership Sustains Flood Damage
- A French Leftist Ritual Takes on Sarkozy
- United States Losing Latin America Market Share
- The Power of Being Multilingual
- Chavez's Obsession With Past Turns Creepy and He's Not Alone
- Obama Could Help Stop Mexico's Bloodshed
- Interdependency Theory: China, India and the West
- The Dangerous Dog Days of Summer
- The Next 500 Years
- A New Plan For Nuclear Postures
- Strengthening the Political - Military Relationship
- Hydraulic Pressures: Into the Age of Water Scarcity?
- South Korea: Prosperity and Anxiety
- China Wealthy? That's Rich!
- Islamism Unveiled: From Berlin to Cairo and Back Again
- Beyond Moderates and Militants: Charting a New Course in the Middle East
- Middle East Peace Talks: Pointless Talks
- Why Israel Can't Rely on Deterrence Against Iran's Nuclear Program
- How to Handle Hamas
- Bringing Israel's Bomb Out of the Basement
- Iraq: Anxious Iraqis Look at Uncertain Future
- Iraq: U.S. Combat Troops' Departure Leaves Uncertainty in its Wake
- Iraq: A Promise Kept?
- An Unlikely Trio: Can Iran Turkey and the United States Become Allies?
- Staying Power: The U.S. Mission in Afghanistan Beyond 2011
- Long Road Ahead for Afghan Security Forces
- Afghanistan's Dirty Little Secret
- Russia's New Nobility
- Mexico Needs U.S. Help But Not Troops
- Mexico's Narco Problems Are Our Problems, and Vice Versa
- No 'I' in 'Team,' but Plenty of 'I' in India
- Afghanistan - There Can Be No Graceful Exit
- Afghanistan Timetable Remains a Factor of Uncertainty
- We Are Playing Fidel Castro's Game
- Has the Time Come to Legalize Drugs?
- Handling Tensions on the Korean Peninsula
- Richard C. Holbrooke: Pakistan Aid Inadequate
- Afghanistan Leaks Answer Few Questions
- Afghanistan & The Karzai Problem
- Afghanistan - Winds of Changing Policy
- Obama's Juggling Act in the Middle East
- Defusing Lebanon's Powder Keg
- Germany's Good Fortune Tips the Scales Against its Neighbors
- End Poverty: Export Capitalism
- Haitian Quake Hasn't Dislodged Status Quo
- Why We Go Back to Haiti
- Iraq - Mission Accomplished II
- The Fight Escalates Against Fake Drugs
- China's Coal Addiction
- Afghanistan: The Pentagon's Lost War
- Afghanistan: The Cost of Nation Building
- Afghanistan: Pentagon Papers Redux?
- Behind Iraq's Long Political Indecision
- Venezuela - Colombia Spat to Pass, Return
- Will China Rule the World?
- NATO's Future Involves More Global Partnerships
- Gloom Awaits U.S. Climate Diplomacy
- U.S. - U.K.: Difficult Duet in Afghanistan
- 'Pariah of the Pacific' Has Ham-handed Grip on Fiji
- Turkey Takes the Veil
- For Israel a Two-State Proposal Starts With Security
- Is It Too Late to Stop Iran
- The Middle East's Private Little War
- Reality and Reform for How the EU Keeps Its Peace
- Chancellor Angela Merkel's Sinking Support
- The Real Reason Why Afghanistan Is a Lost Cause
- The War Drones On
- When the 'Right War' Goes Wrong
- The Afghanistan Paradox
- Pakistan's Gambit in Afghanistan
- Obama Wasting Opportunities in Latin America
- Stopping Nuclear Proliferation Before It Starts
- Veiled Truths: The Rise of Political Islam in the West
- Steps to Stop Iran From Getting a Nuclear Bomb
- Iran: The Nuclear Containment Conundrum
- Iran: The Right Kind Of Containment
- China Is the Key to Handling Nuclear North Korea
- Coping With China's Financial Power
- What China's Currency Reform Means For Investors
- Russian-American Obstacles Overshadow Obama-Medvedev Meeting
- Russia's Courtship of Silicon Valley
- Ukrainian Blues: Viktor Yanukovych's Rise and Democracy's Fall
- Russia: Prisoners of the Caucasus
- The Afghan Challenge Is Far Tougher
- New Guard, Old Policy on Afghanistan
- Fear and Uncertainty in Afghanistan
- Afghanistan: Bribing the Enemy
- Afghanistan Poses Difficult Challenges
- Defining Success in Afghanistan
- Sad Stan, Famous Petraeus
- The Challenge of Reconciliation in Kenya
- The Tyranny of Unity in Zimbabwe
- Mexico: The New Cocaine Cowboys
- Under Santos Colombia Could Rise to the Next Level
- Autocrats' Latest Weapon: Indirect Censorship
- Latin America's Rich Should Be More Generous
- Castrocare in Crisis
(C) 2010 The World Today